Ospedale Maggiore della Carita

Novara 28100

1 studies enrolling now · 6 studies all time

What they study most

Crohn Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Multiple Myeloma, Primary Biliary Cholangitis, Small Lymphocytic Lymphoma, Ulcerative Colitis and Crohn's Disease, Urothelial Cancer

Studies at this site

• A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment — Recruiting now
• A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling
• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab — Stopped early
• A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• Entyvio (Vedolizumab) Long Term Safety Study — Completed